PATENT CLAIM ANALYSIS

Application Number: 15964812
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["546", "152000"]

Abstract:
The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: where A, B, U, V, Z, W 1 , W 2 , W 3 , and R 1 -R 6  are described herein.

Claim (Index 51):
The compound of  claim 50  having the Formula Ib-1:

Metadata:
- Claim Count in Document: 35.0
- Percentile: 91.0
- Lexical Diversity: 1.31111
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14858167', '14858170', '15568051', '14858153', '14858174']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8055654128244096
- 35 USC 102 Novelty (BERT): 0.5275595835447588
- Combined Prediction Score: 0.7777648298964446
- Mean Citation Score: 347.98656800000015
- Max Citation Score: 351.78748
- Similarity Product: 247.0493222084785

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test